BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30724778)

  • 1. Tobacco Treatment Programs at National Cancer Institute-designated Cancer Centers: A Systematic Review and Online Audit.
    Day AT; Tang L; Karam-Hage M; Fakhry C
    Am J Clin Oncol; 2019 Apr; 42(4):407-410. PubMed ID: 30724778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tobacco use treatment at the U.S. National Cancer Institute's designated Cancer Centers.
    Goldstein AO; Ripley-Moffitt CE; Pathman DE; Patsakham KM
    Nicotine Tob Res; 2013 Jan; 15(1):52-8. PubMed ID: 22499079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dedicated Cancer Centers are More Likely to Achieve a Textbook Outcome Following Hepatopancreatic Surgery.
    Mehta R; Tsilimigras DI; Paredes AZ; Sahara K; Dillhoff M; Cloyd JM; Ejaz A; White S; Pawlik TM
    Ann Surg Oncol; 2020 Jun; 27(6):1889-1897. PubMed ID: 32108924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using information technology to integrate tobacco use treatment in routine oncology care: Lessons learned from the U.S. Cancer Center Cessation Initiative Cancer Centers.
    Bird JE; Nguyen CV; Hohl SD; D'Angelo H; Pauk D; Adsit RT; Fiore M; Minion M; McCarthy D; Rolland B
    Implement Res Pract; 2023; 4():26334895231185374. PubMed ID: 37790167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating Tobacco Treatment Into Oncology Care: Reach and Effectiveness of Evidence-Based Tobacco Treatment Across National Cancer Institute-Designated Cancer Centers.
    Hohl SD; Matulewicz RS; Salloum RG; Ostroff JS; Baker TB; Schnoll R; Warren G; Bernstein SL; Minion M; Lenhoff K; Dahl N; Juon HS; Tsosie U; Fleisher L; D'Angelo H; Ramsey AT; Ashing KT; Rolland B; Nolan MB; Bird JE; Nguyen CVT; Pauk D; Adsit RT; Tindle HA; Shoenbill K; Yeung S; Presant CA; Wiseman KP; Wen KY; Chichester LA; Chen LS
    J Clin Oncol; 2023 May; 41(15):2756-2766. PubMed ID: 36473135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pragmatic Application of the RE-AIM Framework to Evaluate the Implementation of Tobacco Cessation Programs Within NCI-Designated Cancer Centers.
    D'Angelo H; Ramsey AT; Rolland B; Chen LS; Bernstein SL; Fucito LM; Webb Hooper M; Adsit R; Pauk D; Rosenblum MS; Cinciripini PM; Joseph A; Ostroff JS; Warren GW; Fiore MC; Baker TB
    Front Public Health; 2020; 8():221. PubMed ID: 32596200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobacco Treatment Program Implementation at NCI Cancer Centers: Progress of the NCI Cancer Moonshot-Funded Cancer Center Cessation Initiative.
    D'Angelo H; Rolland B; Adsit R; Baker TB; Rosenblum M; Pauk D; Morgan GD; Fiore MC
    Cancer Prev Res (Phila); 2019 Nov; 12(11):735-740. PubMed ID: 31481540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Operationalizing Leadership and Clinician Buy-In to Implement Evidence-Based Tobacco Treatment Programs in Routine Oncology Care: A Mixed-Method Study of the U.S. Cancer Center Cessation Initiative.
    Hohl SD; Bird JE; Nguyen CVT; D'Angelo H; Minion M; Pauk D; Adsit RT; Fiore M; Nolan MB; Rolland B
    Curr Oncol; 2022 Mar; 29(4):2406-2421. PubMed ID: 35448169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing Electronic Nicotine Delivery Systems Use at NCI-Designated Cancer Centers in the Cancer Moonshot-funded Cancer Center Cessation Initiative.
    D'Angelo H; Land SR; Mayne RG
    Cancer Prev Res (Phila); 2021 Aug; 14(8):763-766. PubMed ID: 34127508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. US public health service clinical practice guideline: treating tobacco use and dependence.
    Fiore MC
    Respir Care; 2000 Oct; 45(10):1200-62. PubMed ID: 11054899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutrition Education Services Described on National Cancer Institute (NCI)-Designated Cancer Center Websites.
    Polak R; Reilly JM; Elson LE; Gallegos-Kearin VC; Bhatnagar S; Schneider JC; Silver JK
    J Cancer Educ; 2019 Oct; 34(5):860-864. PubMed ID: 29978360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased early mortality associated with the treatment of acute myeloid leukemia at National Cancer Institute-designated cancer centers in California.
    Ho G; Wun T; Muffly L; Li Q; Brunson A; Rosenberg AS; Jonas BA; Keegan THM
    Cancer; 2018 May; 124(9):1938-1945. PubMed ID: 29451695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prevalence of Dissemination and Implementation Research and Training Grants at National Cancer Institute-Designated Cancer Centers.
    Mueller NM; Hsieh A; Ramanadhan S; Lee RM; Emmons KM
    JNCI Cancer Spectr; 2022 Feb; 6(1):. PubMed ID: 35005429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of National Cancer Institute-designated cancer center status: observed variation in surgical care depends on the level of evidence.
    In H; Neville BA; Lipsitz SR; Corso KA; Weeks JC; Greenberg CC
    Ann Surg; 2012 May; 255(5):890-5. PubMed ID: 22504278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of the COVID-19 Pandemic on Tobacco Treatment Program Implementation at National Cancer Institute-Designated Cancer Centers.
    Hohl SD; Shoenbill KA; Taylor KL; Minion M; Bates-Pappas GE; Hayes RB; Nolan MB; Simmons VN; Steinberg MB; Park ER; Ashing K; Beneventi D; Sanderson Cox L; Goldstein AO; King A; Kotsen C; Presant CA; Sherman SE; Sheffer CE; Warren GW; Adsit RT; Bird JE; D'Angelo H; Fiore MC; Van Thanh Nguyen C; Pauk D; Rolland B; Rigotti NA
    Nicotine Tob Res; 2023 Jan; 25(2):345-349. PubMed ID: 35778237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Dedicated Cancer Centers on Outcomes Among Medicare Beneficiaries Undergoing Liver and Pancreatic Cancer Surgery.
    Mehta R; Ejaz A; Hyer JM; Tsilimigras DI; White S; Merath K; Sahara K; Bagante F; Paredes AZ; Cloyd JM; Dillhoff M; Tsung A; Pawlik TM
    Ann Surg Oncol; 2019 Nov; 26(12):4083-4090. PubMed ID: 31376033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Maxillofacial Prosthetics for the Surgically Treated Patient at National Cancer Institute-Designated Comprehensive Cancer Centers.
    Rosen EB; Palin CL; Huryn JM; Wong RJ
    Laryngoscope; 2019 Feb; 129(2):409-414. PubMed ID: 30247745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Most National Cancer Institute-Designated Cancer Center Websites Do Not Provide Survivors with Information About Cancer Rehabilitation Services.
    Silver JK; Raj VS; Fu JB; Wisotzky EM; Smith SR; Knowlton SE; Silver AJ
    J Cancer Educ; 2018 Oct; 33(5):947-953. PubMed ID: 28064402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Availability and integration of palliative care at US cancer centers.
    Hui D; Elsayem A; De la Cruz M; Berger A; Zhukovsky DS; Palla S; Evans A; Fadul N; Palmer JL; Bruera E
    JAMA; 2010 Mar; 303(11):1054-61. PubMed ID: 20233823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.